August 8, 2018 — The U.S. Food and Drug Administration
Volatile substance abuse – a problem that never went away
Drug related deaths are now at their highest levels since
Otonomy Initiates Phase 3 Clinical Trial of Otividex in Ménière’s Disease
SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) — Otonomy, Inc.
Here’s Why Your Pharmacist Won’t Fill Your Prescription — and What You Can Do About It (Part 2)
This is Part 2 in our two-part series on why
Vaxart Announces Publication of the Phase 1 Results of its Oral Norovirus Tablet Vaccine in Journal of Clinical Investigation Insight
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE) July 12, 2018 –Vaxart, Inc.
These pills could be next US drug epidemic, public health officials say
The growing use of anti-anxiety pills reminds some doctors of
KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
CORALVILLE, Iowa, July 09, 2018 (GLOBE NEWSWIRE) — KemPharm, Inc.
FDA Approves Braftovi + Mektovi Combination
BOULDER, Colo., June 27, 2018 /PRNewswire/ — Array BioPharma Inc.
FDA Approves Nocdurna
Parsippany, NJ – June 21, 2018 – The U.S. Food
Treating pain in children can teach us about treating pain in adults
The U.S. government declared a national public health emergency in